The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:325-a-326, February 2006
doi: 10.1176/appi.ajp.163.2.325-a
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by YOHANAN, M.
* Articles by HAWKINS, J. W.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by YOHANAN, M.
* Articles by HAWKINS, J. W.
Related Collections
* Geriatric Psychiatry
* Schizophrenia Spectrum Disorders
* Anticonvulsants

Letter to the Editor

Pisa Syndrome in a Patient in a Wheelchair Taking Valproic Acid

MONIQUE YOHANAN, M.D., JASDEEP S. AULAKH, M.D., JOANNE WEITH, R.N., and JAMES W. HAWKINS, M.D.
Palo Alto, Calif.

To the Editor:

Pisa syndrome (pleurothotonus) is a condition characterized by sustained flexion of the body with the head to one side, creating a "Leaning Tower" posture. It was first described by Ekbom et al. in 1972 (1). General incidence rates are not well established, although it appears to be more common in older patients; an 8% incidence was found in one series of newly admitted geropsychiatric patients (2). Most authors have described Pisa syndrome as a side effect of prolonged exposure to conventional neuroleptics (3). More recently, other agents, including atypical antipsychotics, cholinesterase inhibitors, antiemetics, and tricyclic antidepressants, have been implicated (4). Although treatment with anticholinergic agents has been proposed, definitive therapy remains the discontinuation of the offending agent (5). We report a case of suspected Pisa syndrome in a 65-year-old patient in a wheelchair receiving valproic acid.

Mr. A was a 65-year-old nursing home resident being treated for schizoaffective disorder. He was in a wheelchair secondary to severe arthritis. His medications were 750 mg b.i.d. of valproic acid, 200 mg b.i.d. of carbamazepine, and 3 mg b.i.d. of risperidone—a regimen that had been stable and unchanged over several months. His valproic acid and carbamazepine levels were monitored routinely and were never above the therapeutic range.

Over a few weeks, the staff noticed that Mr. A had begun leaning to one side, a change that progressed to the point at which he was tilted at a 30° angle throughout the day. He seemed unaware of and unconcerned by this change. He showed no other signs or symptoms suggestive of an extrapyramidal syndrome. The only medication change to which Mr. A consented was a trial discontinuation of valproic acid. Immediately upon discontinuation, his posture returned to a stable, upright position.

Pisa syndrome has not been reported in association with valproic acid, but our patient’s dramatic improvement with its discontinuation strongly suggests a medication-related effect, either solely due to valproic acid or perhaps secondary to a pharmacodynamic interaction between valproic acid and risperidone. We believe that this patient’s wheelchair state contributed to a delay in recognizing this condition and hope this report will heighten awareness to the fact that this syndrome can occur in nonambulatory patients.

References

  1. Ekbom K, Lindholm H, Ljungberg L: New dystonic syndrome associated with butyrophenone therapy. Z Neurol 1972; 202:94–103[CrossRef][Medline]
  2. Yassa R, Nastase C, Cvejic J, Laberge G: The Pisa syndrome (or pleurothotonus): prevalence in a psychogeriatric population. Biol Psychiatry 1991; 29:942–945[CrossRef][Medline]
  3. Duggal HS, Sivamony S, Umapathy C: Pisa syndrome and atypical antipsychotics (letter). Am J Psychiatry 2004; 161:373[Free Full Text]
  4. Villarejo A, Camacho A, Garcia-Ramos R, Moreno T, Penas M, Juntas R, Ruiz J: Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 2003; 26:119–121[Medline]
  5. Bhattacharya KF, Giannakikou I, Munroe N, Chaudhuri KR: Primary anticholinergic-responsive Pisa syndrome. Mov Disord 2000; 15:1285–1287[Medline]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by YOHANAN, M.
* Articles by HAWKINS, J. W.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by YOHANAN, M.
* Articles by HAWKINS, J. W.
Related Collections
* Geriatric Psychiatry
* Schizophrenia Spectrum Disorders
* Anticonvulsants


Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org